Proscia
PrivateLast Round
VC Round
Mar 19, 2025
Total Funding Raised
$96.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Proscia is a health care technology company that provides an AI-powered digital pathology platform designed to accelerate cancer research and improve diagnostic workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proscia Comparables
Compare Proscia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Indica Labs | 90% | |
| Techcyte, Inc. | 88% | |
| Tempus | 85% |
Proscia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 19, 2025 | ||||
| Series C Extension | Mar 14, 2024 | ||||
| Series C | Dec 29, 2023 | ||||
| Series C | Jun 14, 2022 | ||||
| Series B | Dec 1, 2020 | ||||
Series A | Sep 26, 2018 |
Key People
Founding team and executive leadership
Proscia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| avenuealtd.com | VC Round |
| Flybridge | Series A |
| TCP Venture Capital | Seed |
| Emerald Development Managers | Series C, VC Round, Series A, Seed |
| Fusion Fund | VC Round, Series A |
| Triangle Peak Partners | Series C, Series C Extension, VC Round |
| HV Fund | Series B, Series C, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 45% MoM.
- Jan 1, 2026
Named "Best in KLAS for Digital Pathology in Europe" and top performer in the U.S.
Recent news
Latest coverage and updates
- recognized_asAug 11, 2026
Proscia Inc. recognized as top score for supporting customers' integration goals.
- has_revenueAug 10, 2026
Proscia Inc. had revenue of $16.4M on Sep 1st '25.
Proscia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Proscia's valuation, stock price, and market status.
Is Proscia a public or private company?
Proscia is a private company.
What is the current stock price of Proscia?
Proscia is a private company with no public stock price. No recent secondary market data is available.
How much is Proscia worth (valuation)?
Valuation information for Proscia is not publicly available.
Can I buy Proscia stock?
Proscia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Proscia's last funding round?
Proscia's most recent funding round was Series C on March 19, 2025.
Who are the main investors in Proscia?
Key investors in Proscia include Flybridge, Emerald Development Managers, Triangle Peak Partners, Scale Venture Partners, Alpha Intelligence Capital.
Will Proscia IPO soon?
No public IPO plans have been announced for Proscia.
How can I track Proscia secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Proscia's secondary market activity and sign up for updates.